These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10369079)

  • 1. Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast carcinomas.
    Sierra A; Castellsague X; Escobedo A; Moreno A; Drudis T; Fabra A
    Breast Cancer Res Treat; 1999 Mar; 54(1):39-45. PubMed ID: 10369079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer.
    Sierra A; Castellsagué X; Escobedo A; Lloveras B; García-Ramirez M; Moreno A; Fabra A
    Int J Cancer; 2000 Mar; 89(2):142-7. PubMed ID: 10754491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
    Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
    Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
    Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer.
    Planas-Silva MD; Bruggeman RD; Grenko RT; Smith JS
    Exp Mol Pathol; 2007 Feb; 82(1):85-90. PubMed ID: 17046747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
    Frolik D; Caduff R; Varga Z
    Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas.
    Bukholm IR; Bukholm G; Nesland JM
    APMIS; 2002 Mar; 110(3):214-20. PubMed ID: 12076274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
    Huang J; Tan PH; Thiyagarajan J; Bay BH
    Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability is associated with the loss of apoptosis in ductal breast carcinomas.
    Méndez O; Máñas S; Peinado ; Fabra A; Escobedo A; Moreno A; Sierra A
    Breast Cancer Res Treat; 2001 Jan; 65(2):171-7. PubMed ID: 11261833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas.
    Sierra A; Castellsagué X; Coll T; Mañas S; Escobedo A; Moreno A; Fabra A
    Int J Cancer; 1998 Apr; 79(2):103-10. PubMed ID: 9583721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
    Terada T; Nakanuma Y
    Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
    Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
    Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.
    Zalata KR; Elshal MF; Foda AA; Shoma A
    Tumour Biol; 2015 Aug; 36(8):6579-84. PubMed ID: 25840688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
    Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
    Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-2 and apoptosis in lymph node positive breast carcinoma.
    Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC
    Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer.
    Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S
    Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of preoperative lymphatic chemotherapy on Bcl-2 and Bax expression in axillary metastasis of breast cancer].
    Wu WJ; Pan CE; Zeng J
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1001-4. PubMed ID: 16109560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of bcl-2 gene expression in human breast cancer tissues.
    Kobayashi S; Iwase H; Ito Y; Yamashita H; Iwata H; Yamashita T; Ito K; Toyama T; Nakamura T; Masaoka A
    Breast Cancer Res Treat; 1997 Jan; 42(2):173-81. PubMed ID: 9138606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-6 oncoprotein in breast cancer: loss of expression in disease progression.
    Pinto AE; André S; Silva G; Vieira S; Santos AC; Dias S; Soares J
    Pathobiology; 2009; 76(5):235-42. PubMed ID: 19816083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.